chr6-44387822-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_001253.4(CDC5L):c.-2A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000652 in 1,564,938 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00035 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000035 ( 0 hom. )
Consequence
CDC5L
NM_001253.4 5_prime_UTR
NM_001253.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.20
Genes affected
CDC5L (HGNC:1743): (cell division cycle 5 like) The protein encoded by this gene shares a significant similarity with Schizosaccharomyces pombe cdc5 gene product, which is a cell cycle regulator important for G2/M transition. This protein has been demonstrated to act as a positive regulator of cell cycle G2/M progression. It was also found to be an essential component of a non-snRNA spliceosome, which contains at least five additional protein factors and is required for the second catalytic step of pre-mRNA splicing. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.23).
BP6
Variant 6-44387822-A-G is Benign according to our data. Variant chr6-44387822-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 3040564.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd4 at 53 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDC5L | NM_001253.4 | c.-2A>G | 5_prime_UTR_variant | 1/16 | ENST00000371477.4 | NP_001244.1 | ||
LOC124901323 | XR_007059595.1 | n.98T>C | non_coding_transcript_exon_variant | 1/4 | ||||
POLR1C | NM_001318876.2 | c.946-54068A>G | intron_variant | NP_001305805.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDC5L | ENST00000371477.4 | c.-2A>G | 5_prime_UTR_variant | 1/16 | 1 | NM_001253.4 | ENSP00000360532 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000348 AC: 53AN: 152210Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
53
AN:
152210
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000625 AC: 11AN: 176070Hom.: 0 AF XY: 0.0000427 AC XY: 4AN XY: 93754
GnomAD3 exomes
AF:
AC:
11
AN:
176070
Hom.:
AF XY:
AC XY:
4
AN XY:
93754
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000347 AC: 49AN: 1412610Hom.: 0 Cov.: 32 AF XY: 0.0000243 AC XY: 17AN XY: 698236
GnomAD4 exome
AF:
AC:
49
AN:
1412610
Hom.:
Cov.:
32
AF XY:
AC XY:
17
AN XY:
698236
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000348 AC: 53AN: 152328Hom.: 0 Cov.: 33 AF XY: 0.000389 AC XY: 29AN XY: 74486
GnomAD4 genome
AF:
AC:
53
AN:
152328
Hom.:
Cov.:
33
AF XY:
AC XY:
29
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
CDC5L-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 18, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at